Mission
Healthy and longevity society with zero cancer deaths and zero dementia
In order to realize a healthy and longevity society, we will promote research and development toward the standardization of heavy-ion cancer radiotherapy and social implementation of the next-generation heavy- ion cancer radiotherapy system "quantum scalpel", as well as research and development of diagnostic and therapeutic technologies for neuropsychiatric diseases, solid tumors, multiple and micro cancers, etc. We will promote research and development from basic to clinical research and actual medical treatment by utilizing the strengths of the QST Hospital in addition to our knowledge of quantum life science and radiation effects research.
Core institutes ▶ Institute for Quantum Medical Science, QST Hospital
Related institutes ▶ Institute for Quantum Life Science, Institute for Radiological Science, Takasaki Institute for Advanced Quantum Science, Kansai Institute for Photon Science
Heavy-ion cancer radiotherapy research
With the aim of expanding insurance coverage of heavy-ion cancer radiotherapy and establishing it as a standard treatment for cancer, we will promote clinical and translational research, including combinatorial therapies effective in improving treatment efficacy, and lead joint clinical research with other treatment facilities.
Development of next-generation heavy-ion cancer radiotherapy system
(Lern more▶Quantum Scalpel Project )
In addition to research and development of a compact next-generation heavy-ion cancer radiotherapy system (Quantum Scalpel) and its social implementation, we will promote research and development of high-precision treatment technologies such as multi-ion irradiation, which combines beams of multiple ion species according to the nature of the tumor to enhance the therapeutic effect.
Diagnostic and therapeutic research on neuropsychiatric disorders
We conduct research and development of technologies for high-accuracy diagnosis and objective assessments of neuropsychiatric disorders represented by dementia and depression. Based on these accomplishments, we promote the drug development to suppress the disease onset and progression and the manipulation of neural circuits for understanding brain functions toward therapeutic controls.
Research on radiopharmaceutical cancer diagnosis and treatment
Using the innovative medical technology of “theranostics” (combination of treatment and diagnosis) utilizing radiopharmaceuticals, we will promote targeted radionuclide therapy (TRT) research, develop radiopharmaceuticals that are effective against multiple and micro cancers, as well as promoting clinical research.
Mission
Social system to protect the public from radiation exposure
As part of research and development to protect the public from radiation exposure, we will contribute to the development of a society that is resilient to various radiation accidents by working on the development and practical application of radiation emergency medicine and dosimetry technologies.
Core institutes ▶ Institute for Radiological Science
Related institutes ▶ QST Hospital, Institute for Quantum Life Science, Institute for Quantum Medical Science
Radiation emergency medical research and improvement of national nuclear disaster countermeasures
As the Core Advanced Radiation Emergency Medical Support Center and a designated national public institution, we will work on technical development, technical support, and training of experts in radiation emergency medicine to enhance nuclear disaster medicine.
We have the Radiation Emergency Medical Assistance Team (REMAT), which provides initial medical support on site in the event of radiation exposure or radioactive contami- medicine nation accidents. REMAT consists of physicians specializing in radiation emergency medicine and experts in radiation protection and dosimetry. In addition, we conduct bioassays for diagnosis and treatment of exposed patients, biological dosimetry, development of techniques for trace analysis of nuclides in environmental samples, and basic research for application of regenerative medicine.
Research on radiation effects and contribution to Fukushima reconstruction assistance
As a technical support organization of the Nuclear Regulation Authority, we will conduct research and development on radiation exposure assessment and radiation health effects based on Japan's experience with the accident at TEPCO Fukushima Daiichi NPS and other incidents, and contribute to support the reconstruction of Fukushima while maintaining an international presence through collaboration with related organizations.
